BCMU
SLXP

BlueCrest Capital Management (UK)’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

BlueCrest Capital Management (UK)’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$505K Buy
+3,230
New +$468K 0.02% 417

Other funds holding SLXP

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlueCrest Capital Management (UK)'s SLXP Position: Q3 2014 in Review

BlueCrest Capital Management (UK) opened a new position in SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q3 2014: 3,230 shares worth $505K. The stake represents 0.02% of the portfolio and ranks #417 among its holdings.

348 funds tracked by Wall St. Rank hold SLXP as of Q3 2014.

  • BlueCrest Capital Management (UK) held 3,230 shares of SALIX PHARMACEUTICALS LTD DEL worth $505K as of Q3 2014.
  • SALIX PHARMACEUTICALS LTD DEL was a new BlueCrest Capital Management (UK) position in Q3 2014.
  • SALIX PHARMACEUTICALS LTD DEL made up 0.02% of BlueCrest Capital Management (UK)'s portfolio in Q3 2014, its #417 holding.
  • 348 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q3 2014.

Based on BlueCrest Capital Management (UK)'s 13F filing for Q3 2014, filed 13 Nov 2014.